Availability of Drugs and Resistance Testing for Bedaquiline, Pretomanid, Linezolid, and Moxifloxacin (Bpal(M)) Regimen for Rifampicin-Resistant Tuberculosis in Europe: Author's Response

AuthID
 P-016-XX7
5
Author(s)
Lange, C
·
Kherabi, Y
·
Guglielmetti, L
·
Günther, G
1
Group Author(s)
Tuberculosis Network European Trials Grp
Tipo de Documento
Letter
Year published
2024
Publicado
in CLINICAL MICROBIOLOGY AND INFECTION, ISSN: 1198-743X
Volume: 30, Número: 9, Páginas: 1207-1208 (2)
Indexing
Wos®
Pubmed®
Publication Identifiers
Pubmed: 38901496
Wos: WOS:001302175500001
Source Identifiers
ISSN: 1198-743X
Export Publication Metadata
Lista Marked
 Adicionar à lista Marked
Info
At this moment we don't have any links to full text documens.

Um espaço para investigadores e suas Instituições

Links Úteis

Ajuda

© 2024 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service